Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
GlobeNewswire, Inc.
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced its intention to offer its...
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
GlobeNewswire, Inc.
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd....
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
- Groundbreaking interim results from the U.S. recurrent glioblastoma REGAIN trial demonstrated 100% local disease control and a 67% complete response rate, followed by FDA clearance to complete trial enrollment and to add two additional leading...
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
GlobeNewswire, Inc.
Antwerp, Belgium, August 10, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that its Board of Directors has proposed the...
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
Covalent Health Wellness and Aesthetics Introduces the Matrix® Platform: A Revolutionary Approach to Skin Health
EIN Presswire
MIAMI, FL, UNITED STATES, August 7, 2026 /EINPresswire.com/ -- Covalent Health Wellness and Aesthetics is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Israel and the occupied territories: ICRC facilitates voluntary return of 88 individuals to Gaza
International Committee of the Red Cross
At the request and with the agreement of relevant authorities, the ICRC transferred the individuals from Kerem Shalom crossing to Nasser Medical Complex in Gaza. Our team also facilitated their communication with families as needed.
Nuvera Aesthetics and Wellness Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
RALEIGH, NC, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- Nuvera Aesthetics and Wellness is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Margate Community to Host Evening Benefiting Soroka Medical Center, Featuring Newsmax Correspondent Sarah Williamson
EIN Presswire
MARGATE, NJ, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- On Sunday, August 16, friends and supporters from across the South Jersey region are invited to gather for Meet & Mingle in Margate, hosted by American Friends of Soroka Medical...
Nuvéra Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
LAGUNA HILLS, CA, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- Nuvéra is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Reverie by Mel B Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
PEARL CITY, HI, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- Reverie by Mel B is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
– Company reports record demand for YCANTH® as dispensed applicator units grew to 19,626 in Q2 2026, up 28.3% over the previous quarter and 46.1% year-over-year – – Topline data from global Phase 3 program studying common warts currently expected...
Dr. Sergio Sokol Scholarship for Future Doctors Opens Applications to Support the Next Generation of Medical Leaders
GlobeNewswire, Inc.
CEDARHURST, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- The Dr. Sergio Sokol Scholarship for Future Doctors is now accepting applications for its 2027 award cycle.
CPE CBRND Equips Joint Force with Lifesaving Nerve Agent Device
DVIDS - Georgia
In a monumental step for warfighter safety and mission readiness, the Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical), a component of the Capability Program Executive for Chemical, Biological,...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.